2Sangha RK, Li SF, Shams M, et al. Fibroblast growth factor receptor 1 is a eritieal eomponent for endometrial remodeling:Loealization and expression of basie fibroblast growth factor and FGFR, in human endometrium during the menstrual cyele and deereased FGF RexPression in menorrhagia [J]. Lab Invest,1997,77(4):389-402.
3SillenM, Prifti S, Koch A, et al. Regulation of metrix metal-loproteinases with and without endometriosis [J]. EurJ Obstet Gyneeol ReProd Biol, 2001,95(2):167-174.
5Daly C, Pasnikowski E, Burova E, et al. Angiopoietin-2 functions as an autocrine protective factor in stressed endothelial cells[J]. Proc Natl Acad Sci USA,2006,103:15491-15496.
6Parikh SM, Mammoto T, Schultz A, et al. Excess circulating giopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans [J]. PLoS Med,2006,3:46.
7Leece G, Meduri G, Aneelin M, et al. Perrot-Applanat:Presence of es- trogen receptor β in the human endometrium through the cycle: expression in glandular, stromal and vasculareells [J]. J Clin Endoerinol Metab, 2001,86:1379-1386.
8Critehley HO, Henderson TA, Kelly RW, et al. Saunders PT:Wild-type estrogen reeeptor (ER-betal) and the splice variant (ERbetacx/beta2) are both expressed within the human endometrium [J]. J Clin Endoerinol Metab,2002,87:5265-5273.
9Bardin A, Boulle N, Lazennec G, et al. Loss of ER expression as a com- mon step in estrogen-depender tumor progression [J]. Endoer Relat Cancer,2004,11 (3):537-551.
2Wang GL,Jiang BH,Semenza GL.Effect of altered redox states on expression and DNA binding activity of hypoxia inducible factor 1[J].Biochem Biopbys Res.Commun,1995,212(2):550-556.
3Wang GL,et al.Hypoxia-inducible factor 1 is a basic-helix-loophelix-PAS heterodimer regulated by cellular O2 tension[J].Proc Natn Acad Sci USA,1995.92 (12):5510-5514.
4Semenza GL,Targeting HIF-1 for cancer therapy[J].Nat Rev Cancer,2003,3(10):721-732.
5Zhong H,De Matzo AM,Langhnet E,et al.Overexpression of hypoxia-inducible factor 1 alpha in common human cancers and their metastases[J].Cancer Res,1999,59(22):5830-5835.
6Kunz M,Ibrahim SM.Molecular responses to hypoxia in tumor cells[J].J Mol Cancer,2003,2(1):23.
7OLKMAN J.Angingenesis in cancer vascular,zheumatoid and other diseaec[J].Nat Med,1995,1:27-31.
8OHTA Y,ENDO Y,TANAKA M,et al.Significance of vascular end othelial growth factor messenger RNA expression in primary lung cancer[J].Clin Res,1996,2:1411-1416.
9NORTON JA.Tumor angiogenesis,The future is now[J].Ann Surg,1995,222(6):693-694.
10ROWN LE,BERSE B,JACKMAN RW,et al.Expression of Vascular permeablity factor(vascular end othelial growth factor) and its receptor in adenocarclnomas of the gastrointestinal tract[J].Cancer Res,1993,53:4727-4735.
